Promaxo Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Series C
- Investors
-
23
Promaxo General Information
Description
Manufacturer of a point-of-care MRI platform intended for office-based prostate interventions. The company offers a single-sided magnet design, an open-bore configuration, deep learning models, automated cancer grading, live visualization, and a transperineal approach, enabling urologists to use real-time visualization during procedures to improve cancer detection rates and patient outcomes.
Contact Information
Website
www.promaxo.comCorporate Office
- 70 Washington Street
- Suite 407
- Oakland, CA 94607
- United States
Corporate Office
- 70 Washington Street
- Suite 407
- Oakland, CA 94607
- United States
Promaxo Timeline
Promaxo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series C) | 22-Oct-2026 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 01-Sep-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 30-Mar-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B3) | 10-Jul-2024 | Completed | Generating Revenue | |||
| 7. Debt - General | 29-Sep-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B2) | 07-Jan-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B1) | 21-May-2020 | Completed | Generating Revenue | |||
| 4. Debt - PPP | 01-May-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 16-Apr-2018 | $5.7M | $5.7M | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | 01-Jun-2017 | Completed | Startup |
Promaxo Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B3 | ||||||||
| Series B2 | ||||||||
| Series B1 | 6,000,000 | $0.000010 | $0.41 | $5.1 | $5.1 | 1x | $5.1 | 22.68% |
| Series A | 3,657,139 | $0.000010 | $0.13 | $1.68 | $1.68 | 1x | $1.68 | 13.82% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Promaxo Comparisons
Industry
Financing
Details
Promaxo Competitors (9)
One of Promaxo’s 9 competitors is Synaptive Medical, a Formerly VC-backed company based in Mississauga, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synaptive Medical | Formerly VC-backed | Mississauga, Canada | ||||
| Focal Healthcare | Accelerator/Incubator Backed | Toronto, Canada | ||||
| Exact Imaging | Venture Capital-Backed | Markham, Canada | ||||
| Koelis | Private Equity-Backed | Meylan, France | ||||
| ZOLL Medical | Corporate Backed or Acquired | Chelmsford, MA |
Promaxo Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Promaxo Patents
Promaxo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026226861-A1 | Coupled transmit coil system for single-sided mri and methods of use thereof | Pending | 24-Apr-2025 | ||
| WO-2026226683-A1 | Systems and methods for needle localization during prostate biopsy | Pending | 22-Apr-2025 | ||
| WO-2026207469-A1 | Systems and methods for real-time needle verification and localization | Pending | 28-Mar-2025 | ||
| WO-2026207309-A1 | Systems and methods for dynamic noise cancellation for mri | Pending | 27-Mar-2025 | ||
| WO-2026096534-A1 | Systems and methods for pelvic floor disorder screening and diagnosis | Pending | 28-Oct-2024 | G01R33/3808 |
Promaxo Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Promaxo Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amara Ventures | Venture Capital | Minority | ||
| New Science Ventures | Venture Capital | Minority | ||
| Woodard Investments | Family Office | Minority | ||
| Angel Physicians Fund | Angel Group | Minority | ||
| Band of Angels | Angel Group | Minority |
Promaxo FAQs
-
When was Promaxo founded?
Promaxo was founded in 2016.
-
Where is Promaxo headquartered?
Promaxo is headquartered in Oakland, CA.
-
What is the size of Promaxo?
Promaxo has 26 total employees.
-
What industry is Promaxo in?
Promaxo’s primary industry is Diagnostic Equipment.
-
Is Promaxo a private or public company?
Promaxo is a Private company.
-
What is Promaxo’s current revenue?
The current revenue for Promaxo is .
-
How much funding has Promaxo raised over time?
Promaxo has raised $208M.
-
Who are Promaxo’s investors?
Amara Ventures, New Science Ventures, Woodard Investments, Angel Physicians Fund, and Band of Angels are 5 of 23 investors who have invested in Promaxo.
-
Who are Promaxo’s competitors?
Synaptive Medical, Focal Healthcare, Exact Imaging, Koelis, and ZOLL Medical are some of the 9 competitors of Promaxo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
